140 related articles for article (PubMed ID: 26737699)
1. Autonomic nervous system response to L-dopa in patients with advanced Parkinson's disease.
Ruonala V; Tarvainen MP; Karjalainen PA; Pekkonen E; Rissanen SM
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():6162-5. PubMed ID: 26737699
[TBL] [Abstract][Full Text] [Related]
2. Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease.
Ludwig J; Remien P; Guballa C; Binder A; Binder S; Schattschneider J; Herzog J; Volkmann J; Deuschl G; Wasner G; Baron R
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):742-5. PubMed ID: 17371906
[TBL] [Abstract][Full Text] [Related]
3. [Сhanges in heart rate variability in presymptomatic and symptomatic stages of Parkinson's disease under pharmacological influences: an experimental study].
Mamalyga ML
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(8):57-60. PubMed ID: 24077553
[TBL] [Abstract][Full Text] [Related]
4. When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease?
De Luka SR; Svetel M; Pekmezović T; Milovanović B; Kostić VS
Vojnosanit Pregl; 2014 Apr; 71(4):346-51. PubMed ID: 24783414
[TBL] [Abstract][Full Text] [Related]
5. Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study.
Kass-Iliyya L; Javed S; Gosal D; Kobylecki C; Marshall A; Petropoulos IN; Ponirakis G; Tavakoli M; Ferdousi M; Chaudhuri KR; Jeziorska M; Malik RA; Silverdale MA
Parkinsonism Relat Disord; 2015 Dec; 21(12):1454-60. PubMed ID: 26578039
[TBL] [Abstract][Full Text] [Related]
6. Effect of a single dose of standard levodopa on cardiac autonomic function in Parkinson's disease.
Sriranjini SJ; Ganesan M; Datta K; Pal PK; Sathyaprabha TN
Neurol India; 2011; 59(5):659-63. PubMed ID: 22019646
[TBL] [Abstract][Full Text] [Related]
7. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
[TBL] [Abstract][Full Text] [Related]
8. Autonomic nervous function in de novo parkinsonian patients in basal condition and after acute levodopa administration.
Quadri R; Comino I; Scarzella L; Cacioli P; Zanone MM; Pipieri A; Bergamasco B; Chiandussi L
Funct Neurol; 2000; 15(2):81-6. PubMed ID: 10916719
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion.
Sydow O
FEBS J; 2008 Apr; 275(7):1370-1376. PubMed ID: 18279380
[TBL] [Abstract][Full Text] [Related]
10. Implications of secondary unresponsiveness to dopaminergic drugs with preserved response to subthalamic nucleus stimulation in Parkinson's disease.
Lenka A; Jhunjhunwala KR; Stezin A; Manjunath M; Srinivas D; Yadav R; Pal PK
Neurol India; 2018; 66(Supplement):S135-S137. PubMed ID: 29503336
[TBL] [Abstract][Full Text] [Related]
11. Autonomic and electrocardiographic findings in Parkinson's disease.
Gibbons CH; Simon DK; Huang M; Tilley B; Aminoff MJ; Bainbridge JL; Brodsky M; Freeman R; Goudreau J; Hamill RW; Luo ST; Singer C; Videnovic A; Bodis-Wollner I; Wong PS;
Auton Neurosci; 2017 Jul; 205():93-98. PubMed ID: 28506500
[TBL] [Abstract][Full Text] [Related]
12. [Initial management and adaptation of Parkinson's disease treatment].
Gérard JM
Rev Med Brux; 2008 Sep; 29(4):229-31. PubMed ID: 18949969
[TBL] [Abstract][Full Text] [Related]
13. Effects of subthalamic nucleus stimulation and levodopa on decision-making in Parkinson's disease.
Atkinson-Clement C; Cavazzini É; Zénon A; Witjas T; Fluchère F; Azulay JP; Baunez C; Eusebio A
Mov Disord; 2019 Mar; 34(3):377-385. PubMed ID: 30681186
[TBL] [Abstract][Full Text] [Related]
14. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
[TBL] [Abstract][Full Text] [Related]
15. Orthostatic heart rate variability analysis in idiopathic Parkinson's disease.
Mihci E; Kardelen F; Dora B; Balkan S
Acta Neurol Scand; 2006 May; 113(5):288-93. PubMed ID: 16629763
[TBL] [Abstract][Full Text] [Related]
16. The association of heart rate variability with parkinsonian motor symptom duration.
Harnod D; Wen SH; Chen SY; Harnod T
Yonsei Med J; 2014 Sep; 55(5):1297-302. PubMed ID: 25048488
[TBL] [Abstract][Full Text] [Related]
17. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
[TBL] [Abstract][Full Text] [Related]
18. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
19. Pallidal deep brain stimulation and L-dopa effect on PET motor activation in advanced Parkinson's disease.
Valálik I; Emri M; Lengyel Z; Mikecz P; Trón L; Csókay A; Márián T
J Neuroimaging; 2009 Jul; 19(3):253-8. PubMed ID: 19021848
[TBL] [Abstract][Full Text] [Related]
20. Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotension.
Bhattacharya KF; Nouri S; Olanow CW; Yahr MD; Kaufmann H
Parkinsonism Relat Disord; 2003 Mar; 9(4):221-4. PubMed ID: 12618057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
